Woman reading in MDC library

Scientific Publications

630 Results:
Active Filter:
Sort:
/ Circulation

AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor

  • R. Dechend
  • V. Homuth
  • G. Wallukat
  • J. Kreuzer
  • J.K. Park
  • J. Theuer
  • A. Juepner
  • D.C. Gulba
  • N. Mackman
  • H. Haller
  • F.C. Luft
/ Am J Pathol

Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy

  • D.N. Mueller
  • E.M.A. Mervaala
  • R. Dechend
  • A. Fiebeler
  • J.K. Park
  • F. Schmidt
  • J. Theuer
  • V. Breu
  • N. Mackman
  • T. Luther
  • W. Schneider
  • D. Gulba
  • D. Ganten
  • H. Haller
  • F.C. Luft
/ Hypertension

Effect of Bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage

  • D.N. Muller
  • E.M.A. Mervaala
  • F. Schmidt
  • J.K. Park
  • R. Dechend
  • E. Genersch
  • V. Breu
  • B.M. Loeffler
  • D. Ganten
  • W. Schneider
  • H. Haller
  • F.C. Luft
/ Hypertension

Hypertension-induced end-organ damage - A new transgenic approach to an old problem

  • F.C. Luft
  • E. Mervaala
  • D.N. Mueller
  • V. Gross
  • F. Schmidt
  • J.K. Park
  • C. Schmitz
  • A. Lippoldt
  • V. Breu
  • R. Dechend
  • D. Dragun
  • W. Schneider
  • D. Ganten
  • H. Haller
/ Oncogene

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel and nuclear co-regulators

  • R. Dechend
  • F. Hirano
  • K. Lehmann
  • V. Heissmeyer
  • S. Ansieau
  • F.G. Wulczyn
  • C. Scheidereit
  • A. Leutz
/ J Am Coll Cardiol

Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction

  • D.C. Gulba
  • P. Tanswell
  • R. Dechend
  • M. Sosada
  • A. Weis
  • J. Waigand
  • F. Uhlich
  • S. Hauck
  • S. Jost
  • W. Rafflenbeul
  • P.R. Lichtlen
  • R. Dietz
/ Hypertension

NF-kappaB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats

  • D.N. Muller
  • R. Dechend
  • E.M.A. Mervaala
  • J.K. Park
  • F. Schmidt
  • A. Fiebeler
  • J. Theuer
  • V. Breu
  • D. Ganten
  • H. Haller
  • F.C. Luft
/ Hypertension

Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes

  • E. Mervaala
  • D.N. Mueller
  • J.K. Park
  • R. Dechend
  • F. Schmidt
  • A. Fiebeler
  • M. Bieringer
  • V. Breu
  • D. Ganten
  • H. Haller
  • F.C. Luft
/ J Am Soc Nephrol

New aspects in the pathophysiology of preeclampsia

  • J.M. Davison
  • V. Homuth
  • A. Jeyabalan
  • K.P. Conrad
  • S.A. Karumanchi
  • S. Quaggin
  • R. Dechend
  • F.C. Luft
/ Fibrinolysis

Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans

  • D.C. Gulba
  • M. Praus
  • R. Dechend
  • S. Hauck
  • M. Mahler
  • R. Zitvz
  • B. Baldus
  • W. Mueller
  • R. Dietz